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Abstract
Introduction:  Lung  ventilation/perfusion  scintigraphy  with  planar  images  (V/QS-planar)  is  very
useful for  the  diagnosis  and  follow-up  of  pulmonary  thromboembolism  (PTE).  Acquiring  tomo-
graphic images  (V/QS-SPECT)  is  a  recent  development  with  potential  to  increase  the  technique’s
accuracy.  The  purpose  of  this  work  is  to  evaluate  the  added  beneﬁts  of  V/QS-SPECT  studies  as
opposed to  traditional  planar  imaging.
Patients  and  methods:  We  prospectively  revised  53  V/QS-planar  and  V/QS-SPECT  exams,  per-
formed according  to  the  European  Association  of  Nuclear  Medicine  guidelines.  We  evaluated  the
exams independently,  by  consensus  of  two  Nuclear  Medicine  physicians.  For  both  methods,  we
gave each  lung  a  score  expressing  the  dimension  and  extension  of  perfusion  defects  with  normal
ventilation.  For  each  lung,  we  compared  the  scores  with  the  paired  Wilcoxon  test,  estimating
the 95%  conﬁdence  interval  (95CI)  for  the  respective  difference.
Results:  We  performed  V/QS-SPECT  exams  without  technical  difﬁculties.  The  paired  Wilcoxon
test estimated  the  score  difference  to  be  −0.75  (95CI  of  −1.0  to  −0.5;  p-value  =  9.6  ×  10−7),
expressing  a  statistically  signiﬁcant  difference  of  about  1  subsegmental  defect  between  both
methods,  with  V/QS-SPECT  detecting  more  defects.
Discussion:  The  results  demonstrate  that  V/QS-SPECT  identiﬁes  a  slightly  larger  number  of
perfusion defects  than  V/QS-planar,  suggesting  a  higher  sensitivity  of  this  technique.  However,
more studies  are  necessary  to  evaluate  the  clinical  meaning  of  this  fact.
Conclusion:  V/QS-SPECT  demonstrates  a  higher  capability  to  identify  perfusion  defects.  This
method looks  promising,  allowing  for  a  greater  role  of  this  exam  in  pulmonary  thromboembolism
diagnosis  and  follow-up.sa  d©  2015  Sociedade  Portugue
reserved.∗ Corresponding author.
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ntroduction and purpose
ulmonary  thromboembolism  (PTE)  is  deﬁned  as  the
mbolization  of  a  blood  clot  to  the  pulmonary  circulation.1
n  fact,  it  is  estimated  that,  in  developed  countries,  it  might
e  present  lifelong  on  up  to  5%  of  the  population.2 It  is  also
iagnosed  in  1.5%  of  hospitalized  patients  and  represents  the
hird  most  frequent  cardiovascular  pathology  (after  myocar-
ial  infarction  and  cerebrovascular  disease).3 Furthermore,
t  carries  a  high  mortality,  up  to  5  to  10%  of  all  in  hospital
eaths.  Therefore,  it  is  a  public  health  problem.2
Acute  PTE  can  present  itself  with  very  distinct  signs
nd  symptoms,  ranging  from  haemodynamic  instability,
cute  pulmonary  hypertension,  cardiac  failure  and  systemic
ypotension1 to  clinically  silent3 forms.
Chronic  PTE  is  frequently  a  cause  for  cardiopulmonary
isease,  originating  pulmonary  infarction,  chronic  pul-
onary  hypertension  and  cor  pulmonale.1
Despite  the  mentioned  clinical  relevance,  PTE  diagnosis
s  not  always  straightforward.3 Therefore,  for  greater  diag-
ostic  accuracy,  imaging  procedures  are  frequently  needed.3
The  imaging  procedures  used  to  diagnose  PTE  can
e  divided  into  anatomical  and  functional  methods.  As
or  the  former,  conventional  pulmonary  angiography  was
rst  described,  which  has  been  superseded  by  comput-
rized  tomography  pulmonary  angiography.3,4 Recently,
agnetic  resonance  pulmonary  angiography  has  begun  to  be
nvestigated.5
Functional  methods  have  been  represented  by  pulmonary
entilation  and  perfusion  scintigraphy  (V/QS),  traditionally
sing  planar  imaging  (V/QS-planar).3 V/QS-planar  consists  in
btaining  two  sets  of  scintigraphic  images  of  the  lungs:  one
epresenting  pulmonary  ventilation  (by  means  of  a radio-
harmaceutical  with  alveolar  air  distribution)  and  another
xhibiting  pulmonary  perfusion  (with  a  radiopharmaceuti-
al  captured  in  the  pulmonary  capillaries).  The  scintigraphic
iagnosis  of  PTE  is  based  on  the  identiﬁcation  of  pulmonary
egments  with  a  perfusion  defect  and  preserved  ventilation,
onsisting  on  a  mismatch  pattern.  In  planar  imaging,  the
cquired  images  represent  a  projection  of  the  totality  of  pul-
onary  ventilation  and  perfusion  in  different  orientations:
nterior,  posterior,  anterior  oblique  and  posterior  oblique,
ore  frequently.
This  procedure  has  been  systematically  improved  in  both
ensitivity  and  speciﬁcity.  In  fact,  since  the  demonstration
f  diagnostic  accuracy  of  V/QS-planar  in  the  PIOPED  study,6,7
ifferent  ways  of  enhancing  the  original  technique  have
een  investigated.  Of  note  are  the  combination  with  results
rom  other  methods,  namely  simple  chest  X-ray,8,9 and  the
ntroduction  of  new  ventilation  radiopharmaceuticals,  such
s  radioaerossols,  which  allow  the  acquisition  of  ventilation
tudies  with  better  diagnostic  quality.10
A  signiﬁcant  advantage  of  scintigraphic  imaging,  as
pposed  to  the  anatomical  methods,  is  a  lower  radiologi-
al  exposure.11 This  is  especially  relevant  when  considering
emale  patients  subject  to  multiple  exams  for  follow-up,
iven  the  high  radiological  sensitivity  of  breast  tissue,  which
s  especially  exposed  to  radiation  in  anatomical  thorax
rocedures.12 Also  in  pregnant  patients,  V/QS  allows  the
eduction  of  radiological  exposure  not  only  to  the  breast,
ut  also  the  foetus,  in  contrast  to  anatomical  methods.13
(
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nother  VQ/S  advantage  is  that  it  does  not  require  the
dministration  of  iodinated  contrast  media,  therefore  pre-
enting  a  more  favourable  pharmacological  safety  proﬁle.
Finally,  V/QS-planar  is  also  the  method  of  choice  in
hronic  PTE  suspicion  as  an  aetiology  for  pulmonary  hyper-
ension,  identifying  those  patients  that  beneﬁt  the  most
rom  directed  therapy.14
The  most  recent  development  in  V/QS  was  the  introduc-
ion  of  pulmonary  ventilation  and  perfusion  tomographic
maging  (V/QS-SPECT).15,16 V/QS-SPECT  has  the  same  con-
eptual  basis  of  V/QS-planar,  the  only  difference  being  that
n  V/QS-SPECT  tomographic  reconstructions  of  pulmonary
entilation  and  perfusion  are  acquired,  allowing  the  evalua-
ion  of  axial,  coronal  and  sagittal  planes.  This  technique  has
 solid  experimental  support,17 appears  to  have  higher  diag-
ostic  sensitivity  than  V/QS-planar18,19 and  does  not  seem  to
mply  additional  resource  consumption.20 Besides,  it  com-
ares  favourably  to  computerized  tomography  pulmonary
ngiography.21,22,23 Its  role  in  clinical  decision  making  is
eginning  to  be  evaluated.24 V/QS-SPECT  also  seems  to  have
 role  in  pulmonary  physiology  investigation.25
The  purpose  of  this  work  is  to  evaluate  the  added  beneﬁts
f  V/QS-SPECT  studies  regarding  the  detection  of  perfusion
efects  compatible  with  PTE  as  opposed  to  traditional  planar
maging.
atients and methods
articipants
e  studied  prospectively  V/QS  exams  performed  on  the
ame  patient  with  both  techniques  under  evaluation  (V/QS-
lanar  and  V/QS-SPECT),  in  order  to  compare  results.
The  study  population  were  the  patients  referred  to
he  authors’  department  to  perform  a  V/QS  for  diagnosis
r  follow-up  of  PTE  from  September  2010  to  September
011.  The  patients  were  referred  by  the  authors’  Institution
utpatient  clinics,  hospital  wards  and  emergency  depart-
ent,  according  to  their  physician’s  clinical  judgement.  We
ncluded  in  the  study,  by  consecutive  sampling,  all  patients
ho  agreed  to  perform  of  both  techniques.  Inability  or
efusal  by  the  patient  to  perform  any  of  the  modalities  were
he  exclusion  criteria.
ethods
e  compared  V/QS-SPECT  to  V/QS-planar,  since  the  lat-
er  is  an  established  technique,  available  in  every  Nuclear
edicine  Department.
We  performed  the  exams  following  the  appropriate  Euro-
ean  Association  of  Nuclear  Medicine  guidelines.26,27 The
xams  were  undertaken  by  an  experienced  Nuclear  Medicine
eam  (Nuclear  Medicine  physicians,  technicians  and  nurses
rained  in  radiopharmaceutical  administration).
For  the  ventilation  study,  the  radiopharmaceutical  used
as  carbon  radioaerossols  marked  with  technetium-99m
Technegas,  Cyclomedica);  and  for  the  perfusion  study,
lbumin  macroaggregates  marked  with  technetium-99m
Macrotec,  GE  Healthcare).  Both  were  administered  with  the
atient  in  the  supine  position.
ography  29
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sion  of  mismatched  defects  identiﬁed  by  V/QS-SPECT  versus
V/QS-planar.  The  other  three  patients  with  different  ﬁnal
results  displayed  PTE  diagnostic  criteria  only  in  V/QS-planar.
Distribution of the number of
global perfusion defects (C/VQ-SPECT)
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Both  planar  and  tomographic  images  were  acquired  in  a
dual  head  gamma-camera  (Millenium  MG,  GE  Healthcare).
Acquisition  was  sequential:  ﬁrst  the  ventilation  study,  with
planar  imaging  followed  by  tomography,  then  the  perfusion
study,  with  tomography  followed  by  planar  imaging.  This
way  we  could  minimize  patient  movement  between  both
tomographic  studies.  We  processed  planar  images  in  a  gen-
eral  nuclear  medicine  workstation  (Xeleris,  GE  Healthcare)
and  the  tomographic  study  with  a  speciﬁc  software  package
(LungSPECT,  Segami).
According  to  the  aforementioned  guidelines,  we  consid-
ered  an  exam  positive  for  PTE  if  it  demonstrated  at  least
one  segmental  perfusion  defect  with  preserved,  or  less  com-
promised,  ventilation  (mismatch  pattern).  For  each  exam
and  technique,  we  scored  each  lung  for  the  number  of  pul-
monary  segments  with  a  mismatch  pattern.  We  considered
subsegmental  defects  as  fractions  of  segmental  defects,  giv-
ing  each  of  them  a  score  of  0.5.  The  scoring  was  done  by  two
Nuclear  Medicine  physicians,  who  had  no  knowledge  of  the
patient  clinical  data  or  the  clinical  report  produced  by  the
physician  in  charge  of  the  exam.  In  those  cases  where  the
initial  opinions  were  divergent,  ﬁnal  consensus  was  reached
after  discussion  between  them.
Statistical  methods
We  compared  the  scoring  of  each  lung  with  the  paired
Wilcoxon  test,  estimating  the  95%  conﬁdence  interval  (95CI)
for  the  difference  between  V/QS-SPECT  and  V/QS-planar.
We  used  the  R  language  and  environment  for  statistical  com-
puting  to  perform  the  statistical  calculations.28
Results
Participants
We  enrolled  patients  for  a  period  of  12  months.  Fifty-three
patients  agreed  to  perform  both  V/QS  modalities,  16  male
and  37  female.  The  median  age  for  the  male  gender  was
54  (min  =  36,  max  =  80)  and  for  the  female  gender  was  56
(min  =  18,  max  =  82).  All  enrolled  patients  successfully  com-
pleted  both  procedures,  none  being  excluded.  Of  the  53
patients,  34  were  referred  for  previous  PTE  re-evaluation
and  19  for  PTE  diagnosis;  43  patients  performed  the  exams
in  an  outpatient  setting  and  10  patients  were  either  admit-
ted  to  a  hospital  ward  or  the  emergency  department  at  the
time.  All  V/QS-SPECT  exams  were  performed  with  the  same
human,  material  and  time  resources  as  V/QS-planar  exams.
Results
We  identiﬁed  30  exams  with  PTE  using  V/QS-planar,  while
the  remainder  23  exams  were  considered  normal.  The
distribution  of  the  number  of  perfusion  defects  with
preserved/less  compromised  ventilation  documented  per
patient  is  presented  in  Fig.  1.  We  observed  that  one-third
of  patients  with  PTE  presents  only  one  segmental  defect
or  equivalent  (n  =  10),  another  third,  two  or  three  defects
(n  =  5  for  both  groups)  and  another  third  presents  four  or
more  segmental  defects  (the  maximum  being  ten  defects).
F
w
pigure  1  Distribution  of  the  number  of  perfusion  defects
ith preserved/less  compromised  ventilation  documented  per
atient  (V/QS-planar);  PTE  diagnosed  for  1  or  more  defects.
Regarding  V/QS-SPECT,  we  identiﬁed  33  patients  with
TE  diagnostic  criteria.  The  maximum  number  of  defects
bserved  was  13.  Fig.  2  presents  this  data  distribution.
In  nine  patients,  the  ﬁnal  conclusions  of  both  modalities
ere  in  disagreement.  In  this  group,  six  patients  presented
TE  diagnostic  criteria  only  in  V/QS-SPECT.  The  difference
n  the  ﬁnal  diagnosis  was  due  to  a  larger  number  and  exten-igure  2  Distribution  of  the  number  of  perfusion  defects
ith preserved/less  compromised  ventilation  documented  per
atient  (V/QS-SPECT);  PTE  diagnosed  for  1  or  more  defects.
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migure  3  V/QS-planar  study;  there  is  some  heterogeneity  in  t
oes not  fulﬁl  PTE  diagnostic  criteria  and  was  disregarded  as  su
owever,  in  two  of  these  patients,  V/QS-SPECT  did  show
erfusion  defects  matched  to  ventilation  defects;  and  on
he  third  patient,  there  was  a  non-segmental  distribution  of
erfusion  defects.  These  features  were  not  clear  in  V/QS-
lanar,  given  the  natural  overlap  of  lung  segments  and
irways  observed  in  this  modality,  which  suggested  a  mis-
atch  pattern  instead.
There  were  no  inconclusive  results  in  both  modalities,
or  there  were  any  adverse  reactions  recorded.
stimateshe  paired  Wilcoxon  test,  applied  to  the  lung  scoring,
videnced  a  difference  of  0.75  between  V/QS-SPECT  and
/QS-planar  (95CI  of  0.45  to  1.00,  p-value  <  0.001).
f
D
nerfusion  of  the  left  lung’s  lower  lobe  (white  arrow),  however  it
iscussion
he  fact  that  all  participants  in  the  study  successfully  com-
leted  both  modalities  demonstrates  that  V/QS-SPECT  does
ot  present  added  technical  difﬁculties  in  relation  to  V/QS-
lanar.  It  is  noteworthy  that  10  patients  performed  the
xams  while  admitted  to  a  hospital  ward  or  the  emer-
ency  department,  settings  in  which  difﬁculties  in  patient
ositioning  and  cooperation  are  usually  expected.  Besides,
/QS-SPECT  did  not  demand  additional  resources  (human,
aterial,  time)  in  relation  to  V/QS-planar.  Therefore  its  per-ormance  presents  no  disadvantages  to  the  patient  or  the
epartment  and  proﬁciency  is  easily  achieved.
We  observed,  in  both  modalities,  a large  dispersion  of  the
umber  of  perfusion  defects  identiﬁed.  This  is  in  agreement
Pulmonary  ventilation/perfusion  single  photon  emission  tomography  31
30/64
TRA
30/64
TRA
W/L:1507/753
30/64
TRA
W/L:1507/753
W/L:4000/2000
0 POST
(11,25)
0 10cm
0 10cm 0 10cm
0 10cm 0 10cm
0 10cm10cm
37/64
SAG
37/64
SAG
37/64
SAG
26/64
COR
TOMO VENT
TOMO PERF
V/Q Ratio
LT
26/64
COR
26/64
COR
RT LT POST
0,5843468
ANT  RT
RT LT POST ANT  RT
LTRT LT POST ANT  RT
LT
ANT
ANT
0 POST 10cm
0 POST 10cm
ANT
r  tha
d
t
a
V
o
w
r
p
VFigure  4  V/QS-SPECT  study,  same  patient  as  before;  it  is  clea
lung’s lower  lobe  (cross-hairs)  fulﬁlling  PTE  diagnostic  criteria.
with  the  known  PTE  clinical  presentation  spectre,  which
goes  from  sub-clinical  to  life-threatening.
We  estimated  a  small,  albeit  statistically  signiﬁcant,  dif-
ference  of  0.75  in  the  scoring  given  to  each  lung  between
V/QS-SPECT  and  V/QS-planar.  This  value  represents  the
V/QS-SPECT  capability  of  identifying  more  perfusion  defects
than  V/QS-planar.  This  is  in  agreement  with  reports  of
larger  sensitivity  for  PTE  diagnosis  using  V/QS-SPECT.18,19 It
should  be  noted  that,  in  those  cases  presenting  disagree-
ment  between  both  modalities,  most  patients  presented  PTE
diagnostic  criteria  in  V/QS-SPECT.Figs.  3,  4  and  5  illustrate  V/QS-SPECT  larger  sensitivity
to  detect  perfusion  defects.  These  examples  demon-
strate  how,  in  one  patient,  V/QS-planar  fails  to  correctly
identify  important  perfusion  defects,  therefore  failing  to
p
s
s
at  there  is  a  perfusion  defect  in  the  superior  segment  of  the  left
iagnose  PTE,  while  V/QS-SPECT  accurately  documents
hem
This  V/QS-SPECT  advantage  results  from  the  technique’s
bility  to  study  each  lung  segment  separately.  In  contrast,
/QS-planar  generates  images  where  different  structures
verlap,  a  limitation  that  might  hide  some  defects  or
rongly  characterize  others.
This  study  did  not  evaluate  V/QS-SPECT  performance
egarding  speciﬁcity.  However,  it  should  be  noted  that  three
atients  presented  PTE  criteria  in  V/QS-planar  and  not  in
/QS-SPECT,  due  to  a  better  deﬁnition  of  ventilation  and
erfusion  defects  by  the  latter  modality.  This  fact  seems  to
upport  the  idea  that  V/QS-SPECT  might  also  present  gains  in
peciﬁcity,  as  opposed  to  V/QS-planar,  as  reported  by  other
uthors.18
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As  such,  V/QS-SPECT  is  poised  to  become  a  method  of
hoice  in  the  diagnosis  and  follow-up  of  PTE,  namely  in
oung  female  patients  or  in  a  pregnancy  setting,29,30 as  well
s  in  patients  which  cannot  be  submitted  to  anatomical
ethods  (mostly  due  to  renal  impairment,  known  allergy
o  radiological  contrast  media  or  incapacity  to  collaborate
ith  the  imaging  protocol).
onclusionse  observed  that  V/QS-SPECT  demonstrates  a  higher
apability  to  identify  perfusion  defects.  This  study  is
n  agreement  with  other  works  ﬁnding  that  V/QS-SPECT
ppears  to  present  a  slight  increase  in  sensitivity  and,
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tudies,  better  characterizing  its  role  on  pulmonary  throm-
oembolism  diagnosis  and  follow-up.
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